{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:11:20Z","timestamp":1785499880079,"version":"3.56.0"},"reference-count":95,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["16\/003"],"award-info":[{"award-number":["16\/003"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["17\/601"],"award-info":[{"award-number":["17\/601"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["22\/198"],"award-info":[{"award-number":["22\/198"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["17-UOA232"],"award-info":[{"award-number":["17-UOA232"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Royal Society of New Zealand Marsden Fund","award":["16\/003"],"award-info":[{"award-number":["16\/003"]}]},{"name":"The Royal Society of New Zealand Marsden Fund","award":["17\/601"],"award-info":[{"award-number":["17\/601"]}]},{"name":"The Royal Society of New Zealand Marsden Fund","award":["22\/198"],"award-info":[{"award-number":["22\/198"]}]},{"name":"The Royal Society of New Zealand Marsden Fund","award":["17-UOA232"],"award-info":[{"award-number":["17-UOA232"]}]},{"name":"The University of Auckland and The Kate Edger Educational Charitable Trust","award":["16\/003"],"award-info":[{"award-number":["16\/003"]}]},{"name":"The University of Auckland and The Kate Edger Educational Charitable Trust","award":["17\/601"],"award-info":[{"award-number":["17\/601"]}]},{"name":"The University of Auckland and The Kate Edger Educational Charitable Trust","award":["22\/198"],"award-info":[{"award-number":["22\/198"]}]},{"name":"The University of Auckland and The Kate Edger Educational Charitable Trust","award":["17-UOA232"],"award-info":[{"award-number":["17-UOA232"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hypoxic-ischemic encephalopathy is brain injury resulting from the loss of oxygen and blood supply around the time of birth. It is associated with a high risk of death or disability. The only approved treatment is therapeutic hypothermia. Therapeutic hypothermia has consistently been shown to significantly reduce the risk of death and disability in infants with hypoxic-ischemic encephalopathy. However, approximately 29% of infants treated with therapeutic hypothermia still develop disability. Recent preclinical and clinical studies have shown that there is still persistent neuroinflammation even after treating with therapeutic hypothermia, which may contribute to the deficits seen in infants despite treatment. This suggests that potentially targeting this persistent neuroinflammation would have an additive benefit in addition to therapeutic hypothermia. A potential additive treatment is Exendin-4, which is a glucagon-like peptide 1 receptor agonist. Preclinical data from various in vitro and in vivo disease models have shown that Exendin-4 has anti-inflammatory, mitochondrial protective, anti-apoptotic, anti-oxidative and neurotrophic effects. Although preclinical studies of the effect of Exendin-4 in perinatal hypoxic-ischemic brain injury are limited, a seminal study in neonatal mice showed that Exendin-4 had promising neuroprotective effects. Further studies on Exendin-4 neuroprotection for perinatal hypoxic-ischemic brain injury, including in large animal translational models are warranted to better understand its safety, window of opportunity and effectiveness as an adjunct with therapeutic hypothermia.<\/jats:p>","DOI":"10.3390\/ijms231710191","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T05:17:23Z","timestamp":1662441443000},"page":"10191","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Targeting Persistent Neuroinflammation after Hypoxic-Ischemic Encephalopathy\u2014Is Exendin-4 the Answer?"],"prefix":"10.3390","volume":"23","author":[{"given":"Kelly Q.","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Physiology, The University of Auckland, Auckland 1142, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simerdeep K.","family":"Dhillon","sequence":"additional","affiliation":[{"name":"Department of Physiology, The University of Auckland, Auckland 1142, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bennet","sequence":"additional","affiliation":[{"name":"Department of Physiology, The University of Auckland, Auckland 1142, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0656-7035","authenticated-orcid":false,"given":"Alistair J.","family":"Gunn","sequence":"additional","affiliation":[{"name":"Department of Physiology, The University of Auckland, Auckland 1142, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne O.","family":"Davidson","sequence":"additional","affiliation":[{"name":"Department of Physiology, The University of Auckland, Auckland 1142, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"ref_1","first-page":"CD003311","article-title":"Cooling for newborns with hypoxic ischaemic encephalopathy","volume":"1","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clp.2018.01.010","article-title":"Therapeutic hypothermia: How can we optimize this therapy to further improve outcomes?","volume":"45","author":"Natarajan","year":"2018","journal-title":"Clin. Perinatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa1315788","article-title":"Effects of hypothermia for perinatal asphyxia on childhood outcomes","volume":"371","author":"Azzopardi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2017.7218","article-title":"Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates with Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial","volume":"318","author":"Shankaran","year":"2017","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1080\/02699052.2019.1597163","article-title":"Attention and visuo-spatial function in children without cerebral palsy who were cooled for neonatal encephalopathy: A case-control study","volume":"33","author":"Tonks","year":"2019","journal-title":"Brain Inj."},{"key":"ref_6","first-page":"8","article-title":"School-age outcomes of children without cerebral palsy cooled for neonatal hypoxic-ischaemic encephalopathy in 2008\u20132010","volume":"105","author":"Jary","year":"2019","journal-title":"Arch. Dis. Child.-Fetal Neonatal Ed."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"102872","DOI":"10.1016\/j.nicl.2021.102872","article-title":"Motor function and white matter connectivity in children cooled for neonatal encephalopathy","volume":"32","author":"Spencer","year":"2021","journal-title":"NeuroImage Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1273","DOI":"10.1016\/S2214-109X(21)00264-3","article-title":"Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): A randomised controlled trial in India, Sri Lanka, and Bangladesh","volume":"9","author":"Thayyil","year":"2021","journal-title":"Lancet Glob Health"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/pr.2013.206","article-title":"Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990","volume":"74","author":"Lee","year":"2013","journal-title":"Pediatr. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10142","DOI":"10.1038\/s41598-019-46505-0","article-title":"Differential effects of slow rewarming after cerebral hypothermia on white matter recovery after global cerebral ischemia in near-term fetal sheep","volume":"9","author":"Draghi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12974-022-02499-7","article-title":"Persistent cortical and white matter inflammation after therapeutic hypothermia for ischemia in near-term fetal sheep","volume":"19","author":"Zhou","year":"2022","journal-title":"J. Neuroinflammation."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/brain\/awy220","article-title":"Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy","volume":"141","author":"Poupon","year":"2018","journal-title":"Brain"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/dmcn.14610","article-title":"Combination treatments with therapeutic hypothermia for hypoxic-ischemic neuroprotection","volume":"62","author":"Zhou","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1113\/JP274928","article-title":"A working model for hypothermic neuroprotection","volume":"596","author":"Wassink","year":"2018","journal-title":"J. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/brain\/awn150","article-title":"Supra- and sub-baseline phosphocreatine recovery in developing brain after transient hypoxia-ischaemia: Relation to baseline energetics, insult severity and outcome","volume":"131","author":"Iwata","year":"2008","journal-title":"Brain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.2741\/4700","article-title":"Perinatal brain injury: Mechanisms and therapeutic approaches","volume":"23","author":"Davidson","year":"2018","journal-title":"Front. Biosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/jcbfm.2014.259","article-title":"How long is too long for cerebral cooling after ischemia in fetal sheep?","volume":"35","author":"Davidson","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1113\/jphysiol.2006.105197","article-title":"Relationship between evolving epileptiform activity and delayed loss of mitochondrial activity after asphyxia measured by near-infrared spectroscopy in preterm fetal sheep","volume":"572","author":"Bennet","year":"2006","journal-title":"J. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mvr.2012.09.007","article-title":"Morphological evaluation of the cerebral blood vessels in the late gestation fetal sheep following hypoxia in utero","volume":"85","author":"Baburamani","year":"2013","journal-title":"Microvasc. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuroscience.2007.06.060","article-title":"Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as \u201ccontinuum\u201d phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain","volume":"149","author":"Northington","year":"2007","journal-title":"Neuroscience"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.22419","article-title":"Neuronal cell death in neonatal hypoxia-ischemia","volume":"69","author":"Northington","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000046144","article-title":"Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors","volume":"23","author":"Ness","year":"2001","journal-title":"Dev. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/01.WCB.0000123906.17746.00","article-title":"Neural stem cells in the subventricular zone are resilient to hypoxia\/ischemia whereas progenitors are vulnerable","volume":"24","author":"Romanko","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jnen\/nlx046","article-title":"Insights into the Neuroinflammatory Responses After Neonatal Hypoxia-Ischemia","volume":"76","author":"Jaworska","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000046146","article-title":"Human perinatal asphyxia: Correlation of neonatal cytokines with MRI and outcome","volume":"23","author":"Dickens","year":"2001","journal-title":"Dev. Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1203\/01.PDR.0000144819.45689.BB","article-title":"Neonatal encephalopathy: Association of cytokines with MR spectroscopy and outcome","volume":"56","author":"Bartha","year":"2004","journal-title":"Pediatr. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.22049","article-title":"Altered inflammatory responses in preterm children with cerebral palsy","volume":"68","author":"Lin","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12987-015-0002-1","article-title":"Differential cytokine expression by brain microglia\/macrophages in primary culture after oxygen glucose deprivation and their protective effects on astrocytes during anoxia","volume":"12","author":"Barakat","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fneur.2015.00081","article-title":"The ischemic environment drives microglia and macrophage function","volume":"6","author":"Fumagalli","year":"2015","journal-title":"Front. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000328989","article-title":"The yin and yang of microglia","volume":"33","author":"Czeh","year":"2011","journal-title":"Dev. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1471-4159.2006.04162.x","article-title":"Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke","volume":"100","author":"Denker","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-3806(94)00177-2","article-title":"Microglia activation after neonatal hypoxic-ischemia","volume":"84","author":"McRae","year":"1995","journal-title":"Brain Res. Dev. Brain Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Fleiss, B., Van Steenwinckel, J., Bokobza, C., Shearer, I.K., Ross-Munro, E., and Gressens, P. (2021). Microglia-mediated neurodegeneration in perinatal brain injuries. Biomolecules, 11.","DOI":"10.3390\/biom11010099"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1750-3639.2008.00138.x","article-title":"Amoeboid microglia in the periventricular white matter induce oligodendrocyte damage through expression of proinflammatory cytokines via MAP kinase signaling pathway in hypoxic neonatal rats","volume":"18","author":"Deng","year":"2008","journal-title":"Brain Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/jnr.24761","article-title":"White matter injury in the neonatal hypoxic-ischemic brain and potential therapies targeting microglia","volume":"99","author":"Shao","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.reprotox.2014.04.002","article-title":"Microglia toxicity in preterm brain injury","volume":"48","author":"Baburamani","year":"2014","journal-title":"Reprod. Toxicol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1177\/0271678X20963405","article-title":"Microglia\/macrophage polarization: Fantasy or evidence of functional diversity?","volume":"40","author":"Hu","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000346685","article-title":"Cerebral and hepatic inflammatory response after neonatal hypoxia-ischemia in newborn rats","volume":"35","author":"Bonestroo","year":"2013","journal-title":"Dev. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12974-017-0807-8","article-title":"The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia","volume":"14","author":"Jaworska","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"ref_41","first-page":"286","article-title":"Temporal characterization of microglia\/macrophage phenotypes in a mouse model of neonatal hypoxic-ischemic brain injury","volume":"10","author":"Hellstrom","year":"2016","journal-title":"Front. Cell Neurosci"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: The good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/1871527311312030007","article-title":"Age-dependent microglial activation in immature brains after hypoxia- ischemia","volume":"12","author":"Ferrazzano","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2015.12.004","article-title":"Suppression of microglia activation after hypoxia-ischemia results in age-dependent improvements in neurologic injury","volume":"291","author":"Cikla","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Winerdal, M., Winerdal, M.E., Kinn, J., Urmaliya, V., Winqvist, O., and Aden, U. (2012). Long lasting local and systemic inflammation after cerebral hypoxic ischemia in newborn mice. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036422"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"25178","DOI":"10.1038\/srep25178","article-title":"Extending the duration of hypothermia does not further improve white matter protection after ischemia in term-equivalent fetal sheep","volume":"6","author":"Davidson","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0271678X17729954","article-title":"Delayed intranasal infusion of human amnion epithelial cells improves white matter maturation after asphyxia in preterm fetal sheep","volume":"39","author":"Fraser","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1203\/00006450-199904010-00008","article-title":"Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats","volume":"45","author":"Bona","year":"1999","journal-title":"Pediatr. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neulet.2013.10.046","article-title":"Dual role of astrocytes in perinatal asphyxia injury and neuroprotection","volume":"565","author":"Romero","year":"2014","journal-title":"Neurosci. Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrn3898","article-title":"Astrocyte barriers to neurotoxic inflammation","volume":"16","author":"Sofroniew","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1523\/JNEUROSCI.11-11-03398.1991","article-title":"Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes","volume":"11","author":"McKeon","year":"1991","journal-title":"J. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","article-title":"The Role of Astrocytes in CNS Inflammation","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijdevneu.2017.07.006","article-title":"Galantamine administration reduces reactive astrogliosis and upregulates the anti-oxidant enzyme catalase in rats submitted to neonatal hypoxia ischemia","volume":"62","author":"Odorcyk","year":"2017","journal-title":"Int. J. Dev. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1177\/0271678X16650455","article-title":"Partial white and grey matter protection with prolonged infusion of recombinant human erythropoietin after asphyxia in preterm fetal sheep","volume":"37","author":"Wassink","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2010.01.010","article-title":"Morphological changes in white matter astrocytes in response to hypoxia\/ischemia in the neonatal pig","volume":"1319","author":"Sullivan","year":"2010","journal-title":"Brain Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11910-019-0916-0","article-title":"Therapeutic hypothermia in neonatal hypoxic-ischemic encephalopathy","volume":"19","author":"Wassink","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1742-2094-9-164","article-title":"Time-dependent effects of hypothermia on microglial activation and migration","volume":"9","author":"Seo","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.WCB.0000059566.39780.8D","article-title":"Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke","volume":"23","author":"Han","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1523\/JNEUROSCI.22-10-03921.2002","article-title":"Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimental stroke and inflammation","volume":"22","author":"Han","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0306-4522(02)00350-0","article-title":"Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia\/monocyte accumulation following experimental stroke","volume":"114","author":"Wang","year":"2002","journal-title":"Neuroscience"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41390-019-0475-8","article-title":"Protection of axonal integrity with 48 or 72 h of cerebral hypothermia in near-term fetal sheep","volume":"88","author":"Zhou","year":"2020","journal-title":"Pediatr. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12974-021-02314-9","article-title":"Hypothermia modulates myeloid cell polarization in neonatal hypoxic-ischemic brain injury","volume":"18","author":"Seitz","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12974-020-01792-7","article-title":"Aggravated brain injury after neonatal hypoxic ischemia in microglia-depleted mice","volume":"17","author":"Tsuji","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pep.2004.10.014","article-title":"Expression and purification of exendin-4, a GLP-1 receptor agonist, in Escherichia coli","volume":"41","author":"Yin","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/bcpt.13169","article-title":"Exendin-4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant","volume":"124","author":"Yap","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2007.11.016","article-title":"Single- and multiple-dose pharmacokinetics of exendin-4 in rhesus monkeys","volume":"353","author":"Ai","year":"2008","journal-title":"Int. J. Pharm."},{"key":"ref_67","first-page":"E458","article-title":"Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig","volume":"271","author":"Deacon","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jdiacomp.2011.03.002","article-title":"Psychological and quality of life changes in patients using GLP-1 analogues","volume":"25","author":"Grant","year":"2011","journal-title":"J. Diabetes Complicat."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/WNR.0000000000000046","article-title":"Related expressional change of HIF-1\u03b1 to the neuroprotective activity of exendin-4 in transient global ischemia","volume":"25","author":"Jin","year":"2014","journal-title":"Neuroreport"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainres.2011.10.026","article-title":"Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats","volume":"1427","author":"Briyal","year":"2012","journal-title":"Brain Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1208\/s12248-015-9854-1","article-title":"Intranasal Delivery of Exendin-4 Confers Neuroprotective Effect Against Cerebral Ischemia in Mice","volume":"18","author":"Zhang","year":"2016","journal-title":"AAPS J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuint.2019.04.006","article-title":"Exendin-4 attenuates brain mitochondrial toxicity through PI3K\/Akt-dependent pathway in amyloid beta (1-42)-induced cognitive deficit rats","volume":"128","author":"Garabadu","year":"2019","journal-title":"Neurochem. Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3389\/fnins.2020.00785","article-title":"PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson\u2019s Disease","volume":"14","author":"Yu","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8905917","DOI":"10.1155\/2019\/8905917","article-title":"Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway","volume":"2019","author":"Wei","year":"2019","journal-title":"J. Diabetes Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3389\/fimmu.2018.01291","article-title":"Inflammation-Induced Adverse Pregnancy and Neonatal Outcomes Can Be Improved by the Immunomodulatory Peptide Exendin-4","volume":"9","author":"Romero","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/jcbfm.2011.51","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia","volume":"31","author":"Teramoto","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1007\/s12035-017-0550-2","article-title":"Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses","volume":"55","author":"Lee","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Darsalia, V., Hua, S., Larsson, M., Mallard, C., Nathanson, D., Nystr\u00f6m, T., Sj\u00f6holm, \u00c5., Johansson, M.E., and Patrone, C. (2014). Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103114"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2017.12.005","article-title":"Both classic Gs-cAMP\/PKA\/CREB and alternative Gs-cAMP\/PKA\/p38\u03b2\/CREB signal pathways mediate exenatide-stimulated expression of M2 microglial markers","volume":"316","author":"Wu","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pharep.2015.10.008","article-title":"Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes\/macrophages in a protein kinase A and B\/Akt manner","volume":"68","author":"Machnik","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jdi.12063","article-title":"Anti-inflammatory effects of exendin-4, a glucagon-like peptide-1 analog, on human peripheral lymphocytes in patients with type 2 diabetes","volume":"4","author":"He","year":"2013","journal-title":"J. Diabetes Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5607\/en.2017.26.4.227","article-title":"Anti-inflammatory Effect of Glucagon Like Peptide-1 Receptor Agonist, Exendin-4, through Modulation of IB1\/JIP1 Expression and JNK Signaling in Stroke","volume":"26","author":"Kim","year":"2017","journal-title":"Exp. Neurobiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"105969","DOI":"10.1016\/j.intimp.2019.105969","article-title":"Glucagon-like peptide-1 receptor agonist exendin-4 mitigates lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages","volume":"77","author":"Lu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"111932","DOI":"10.1016\/j.bbr.2019.111932","article-title":"Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5\u00d7FAD mouse model of Alzheimer\u2019s disease","volume":"370","author":"An","year":"2019","journal-title":"Behav. Brain Res."},{"key":"ref_85","first-page":"4837","article-title":"Neuroprotective effects of exendin-4 in rat model of spinal cord injury via inhibiting mitochondrial apoptotic pathway","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-0028-1105911","article-title":"Anti-apoptotic action of exendin-4 in INS-1 beta cells: Comparative protein pattern analysis of isolated mitochondria","volume":"41","author":"Tews","year":"2009","journal-title":"Horm. Metab. Res."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Li, Z., Zhou, Z., Huang, G., Hu, F., Xiang, Y., and He, L. (2013). Exendin-4 protects mitochondria from reactive oxygen species induced apoptosis in pancreatic Beta cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076172"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1111\/j.1742-4658.2007.05890.x","article-title":"CREB and cAMP response element-mediated gene expression in the ischemic brain","volume":"274","author":"Kitagawa","year":"2007","journal-title":"FEBS J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/fcp.12192","article-title":"Exenatide enhances cognitive performance and upregulates neurotrophic factor gene expression levels in diabetic mice","volume":"30","author":"Gumuslu","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00418-015-1333-3","article-title":"Neurotrophic and neuroprotective properties of exendin-4 in adult rat dorsal root ganglion neurons: Involvement of insulin and RhoA","volume":"144","author":"Tsukamoto","year":"2015","journal-title":"Histochem. Cell Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neulet.2010.09.040","article-title":"Chronic treatment of exendin-4 affects cell proliferation and neuroblast differentiation in the adult mouse hippocampal dentate gyrus","volume":"486","author":"Li","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41390-020-0827-4","article-title":"Continuous glucose monitoring profile during therapeutic hypothermia in encephalopathic infants with unfavorable outcome","volume":"88","author":"Montaldo","year":"2020","journal-title":"Pediatr. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1021\/jm9909645","article-title":"Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration","volume":"43","author":"Knudsen","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fncel.2019.00585","article-title":"Treatment with Liraglutide Exerts Neuroprotection After Hypoxic-Ischemic Brain Injury in Neonatal Rats via the PI3K\/AKT\/GSK3\u03b2 Pathway","volume":"13","author":"Zeng","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"J. Med. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/17\/10191\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:23:47Z","timestamp":1760142227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/17\/10191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":95,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["ijms231710191"],"URL":"https:\/\/doi.org\/10.3390\/ijms231710191","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]}}}